Global addiction treatment market is estimated to be valued at USD 9.51 Bn in 2024, and is expected to exhibit a CAGR of 5.6% during the forecast period (2024-2031). Addiction is a chronic health condition that affects millions globally. It impacts individuals physically as well as emotionally and economically. The complexity of addiction demands professional treatment approaches to facilitate recovery. The addiction treatment market encompasses a wide range of services from detoxification and rehabilitation to continuing care. Advancements in neuroscience have deepened the understanding of addiction and influenced treatment modalities. Therapies are becoming increasingly tailored to address co-occurring disorders as well as the psychological and social aspects of addiction. The market is witnessing rising demand for evidence-based and holistic treatment options.

Market Dynamics:

The global addiction treatment market is driven by the rising prevalence of substance abuse disorders fueled by easy access to addictive substances. According to the United Nations, around 271 million people globally use drugs at least once a year. Increasing awareness about effective treatment options and reduced stigma associated with seeking help are creating growth opportunities for industry players. However, the market potential remains relatively untapped in developing nations due to lack of screening and treatment infrastructure as well as social barriers. High treatment costs also restrain the market growth to some extent. The market is poised to gain from the growing acceptance of medication-assisted treatment approaches and expansion of telehealth offerings during the pandemic.

Key Features of the Study:

• This report provides an in-depth analysis of the global addiction treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global addiction treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this includes Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Alkremes Plc., Glenmark Pharmaceuticals, GSK plc, Johnson & Johnson Services, Inc., Novartis AG, Perrigo Company plc., Cipla , Dr. Reddy’s Laboratories Limited, Hikma Pharmaceuticals Plc., Indivior Inc., Mylan N.V., Eli Lilly and Company, Tempero Bio, BioCorRx Inc., and Opiant Pharmaceuticals Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global addiction treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global addiction treatment market

Detailed Segmentation-

• By Type:
• • Alcohol Addiction
  • Tobacco/Nicotine Addiction
  • Opioid Addiction
  • Others
• By Drug Type:
• • Opioids
    • Buprenorphine
    • Methadone
    • Naltrexone
  • Nicotine Replacement Therapies
    • Nicotine Gums
    • Nicotine Patches
    • Nicotine Lozenges
    • Nicotine Spray
  • Non-Nicotine Medication
  • Varenicline
  • Bupropion 
• By Distribution Channel:
• • Hospital Pharmacies
  • Medical Stores
  • Others
• By Region:
• • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer, Inc.
  • Alkremes Plc.
  • Glenmark Pharmaceuticals
  • GSK plc
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Perrigo Company plc.
  • Cipla 
  • Reddy’s Laboratories Limited
  • Hikma Pharmaceuticals Plc.
  • Indivior Inc.
  • Mylan N.V.
  • Eli Lilly and Company
  • Tempero Bio
  • BioCorRx Inc.
  • Opiant Pharmaceuticals Inc.